Home
 Search
 Category
 Compounds
 Status
 Download
 Contacts
 Resources


Compound category: Carboxylic acids and derivatives
(total 14 related compounds in database, current show from 11 to 14)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
2-hydroxy-5-[5-[(E)-3-[[3-[[3-(4-hydroxyphenyl)-1,2,4-thiadiazol-5-yl]amino]-3-oxopropyl]amino]-3-oxoprop-1-enyl]furan-2-yl]benzoic acid Depiction based on curated SMILES O O OH O OH HO N S N N H O N H Yersinia TTSS secreted effectors Preclinical (in vitro) Leone M, et al. 2010. Chem Biol Drug Des
5-cyano-6-[(4-methylphenyl)methylsulfanyl]pyridine-2-carboxylic acid Depiction based on curated SMILES N N HO O CH 3 S Escherichia
Yersinia		 TTSS (Type III secretion system)
TTSS (Type III secretion system)		 Preclinical (in vitro)
Preclinical (in vitro)		 Pan NJ, et al. 2009. Antimicrob Agents Chemother
5-[5-[(E)-3-[[(1S)-1-carboxy-2-(4-nitrophenyl)ethyl]amino]-3-oxoprop-1-enyl]furan-2-yl]-2-hydroxybenzoic acid Depiction based on curated SMILES + N O N H O _ O O OH O O OH OH Yersinia TTSS secreted effectors Preclinical (in vitro) Leone M, et al. 2010. Chem Biol Drug Des
5-[5-[(E)-3-[[3-[[4-(3,4-difluorophenyl)-1,3-thiazol-2-yl]amino]-3-oxopropyl]amino]-3-oxoprop-1-enyl]furan-2-yl]-2-hydroxybenzoic acid Depiction based on curated SMILES O N H N N H F F S O O OH HO O Yersinia TTSS secreted effectors Preclinical (in vitro) Leone M, et al. 2010. Chem Biol Drug Des
   
   
   
   
   
   
   
   
   
   
   
   
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page  1  2 



Back to top
2004-2024 NIPB, CAMS&PUMC